Abstract |
The process of covalent immunochemical linking of viable cell membranes with a Simian Virus 40 (SV40) tumor antigen-derived undecapeptide, K(698)PPTPPPEPET(708) (KT), is described. The principle applied was the reaction of the lysine residue, K 698, of the undecapeptide with the succinimidyl moiety of a heterobifunctional linker molecule, N-succinimidyl-3-(2-pyridyldithio)propionate (SPDP) or sulfosuccinimidyl(4-iodo-acetyl)aminobenzoate (sulfo-SIAB). Thereby, upon release of N-hydroxy-succinimide, the rest of the linker molecule reacts covalently with the epsilon-NH2 group of lysine. Upon release of pyridyl-2-thion or hydrogen iodide, respectively, the second reactive moiety of the linker is then ready to form a covalent bond with SH-groups of cell membrane compounds. As a result, KT is covalently linked onto the cell membrane by an -SS- or an -S-bond, respectively. Binding is prevented by treatment of the candidate cells with iodoacetamide, an SH-reactive compound. This artificial cell membrane epitope can be demonstrated by surface immunofluorescence and by binding to immunomagnetic beads loaded with PAb1605, a KT-specific monoclonal antibody. Quantitation by cytofluorimetry shows some 10(4) KT molecules bound per cell, a number that is in the range of the number of SV40 tumor antigen molecules of genuine SV40-transformed mammalian cells.
|
Authors | R Hess, P Rau, M Schwab, S Paetzold, M Kuther, M Obert, H Agostini, C Haessler, D G Braun, G Brandner |
Journal | Peptide research
(Pept Res)
Vol. 7
Issue 3
Pg. 146-52
( 1994)
ISSN: 1040-5704 [Print] United States |
PMID | 7521699
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Polyomavirus Transforming
- Cross-Linking Reagents
- Epitopes
- K698-T708 undecapeptide
- Oligopeptides
- Vaccines
|
Topics |
- Animals
- Antigens, Polyomavirus Transforming
(chemistry)
- Cell Membrane
(chemistry)
- Cross-Linking Reagents
- Epitopes
(chemistry)
- Flow Cytometry
- Fluorescent Antibody Technique
- Lymphoid Tissue
(cytology)
- Mice
- Neoplasms, Experimental
(therapy)
- Oligopeptides
(chemistry, immunology)
- Vaccines
(chemistry)
|